Registration of securities issued in business combination transactions

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

v3.21.2
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
3 Months Ended
Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS  
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 2   —  RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

The Company previously accounted for its outstanding Public Warrants (as defined in Note 5) and Private Placement Warrants (collectively, with the Public Warrants, the “Warrants”) issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the Warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of  the warrant. In addition, the warrant agreement includes a provision that in the event of a tender or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of common stock, all holders of the Warrants would be entitled to receive cash for their Warrants (the “tender offer provision”).

In connection with the audit of the Company’s financial statements for the period ended December 31, 2020, the Company’s management further evaluated the Warrants under Accounting Standards Codification (“ASC”) Subtopic 815‑40, Contracts in Entity’s Own Equity. ASC Section 815‑40‑15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815‑40‑15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company’s Private Placement Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC Section 815‑40‑15 as described above. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded the tender offer provision included in the warrant agreement fails the “classified in stockholders’ equity” criteria as contemplated by ASC Section 815‑40‑25.

As a result of the above, the Company should have classified the Warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the Warrants at the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results for the current period.

The Company’s accounting for the Warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported operating expenses, cash flows or cash.

 

 

 

 

 

 

 

 

 

 

 

    

As

    

 

    

    

 

    

 

 

Previously

 

 

 

 

As

 

 

Reported

 

Adjustments

 

Restated

Balance sheet as of December 4, 2020

 

 

 

 

 

 

 

 

 

Warrant Liability

 

$

 —

 

$

18,190,000

 

$

18,190,000

Common Stock Subject to Possible Redemption

 

 

217,972,620

 

 

(18,190,000)

 

 

199,782,620

Common Stock

 

 

695

 

 

182

 

 

877

Additional Paid-in Capital

 

 

5,000,411

 

 

701,197

 

 

5,701,608

Accumulated Deficit

 

 

(1,096)

 

 

(701,379)

 

 

(702,475)

Balance sheet as of December 31, 2020

 

 

  

 

 

  

 

 

  

Warrant Liability

 

$

 —

 

$

19,780,000

 

$

19,780,000

Common Stock Subject to Possible Redemption

 

 

217,771,437

 

 

(19,780,007)

 

 

197,991,430

Common Stock

 

 

697

 

 

198

 

 

895

Additional Paid-in Capital

 

 

5,201,592

 

 

2,291,188

 

 

7,492,780

Accumulated Deficit

 

 

(202,287)

 

 

(2,291,379)

 

 

(2,493,666)

Stockholders’ Equity

 

 

5,000,002

 

 

 7

 

 

5,000,009

 

 

 

 

 

 

 

 

 

 

 

 

    

As 

    

 

 

    

 

 

 

 

Previously

 

 

 

 

As 

 

 

 Reported

 

Adjustments 

 

Restated

Statement of Operations for the Period from September 23, 2020 (inception) to December 31, 2020

 

 

  

 

 

  

 

 

  

Change in fair value of Warrants

 

$

 —

 

$

(1,590,000)

 

$

(1,590,000)

Transaction costs attributable to Warrants

 

 

 —

 

 

(701,379)

 

 

(701,379)

Net loss

 

 

(202,287)

 

 

(2,291,379)

 

 

(2,493,666)

Weighted average shares outstanding, Common stock subject to possible redemption

 

 

21,797,262

 

 

(1,819,000)

 

 

19,978,262

Basic and diluted net income per share, Common stock subject to possible redemption

 

 

 —

 

 

 —

 

 

 —

Weighted average shares outstanding, Common stock

 

 

6,081,367

 

 

501,153

 

 

6,582,520

Basic and diluted net loss per share, Common stock

 

 

(0.03)

 

 

(0.34)

 

 

(0.37)

Cash Flow Statement for the Period from September 23, 2020 (inception) to December 31, 2020

 

 

  

 

 

  

 

 

  

Net loss

 

$

(202,287)

 

$

(2,291,379)

 

$

(2,493,666)

Change in fair value of Warrants

 

 

 —

 

 

1,590,000

 

 

1,590,000

Transaction costs attributable to Warrants

 

 

 —

 

 

701,379

 

 

701,379

Initial classification of common stock subject to possible redemption

 

 

217,972,620

 

 

(18,190,000)

 

 

199,782,620

Change in value of common stock subject to possible redemption

 

 

(201,183)

 

 

(1,590,007)

 

 

(1,791,190)

 

Statement of Changes in Stockholders’ Equity for the Period from September 23, 2020 (inception) to December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock

 

Additional Paid-in

 

Accumulated   

 

Total Stockholders’

 

 

Shares

 

Amount

 

Capital

 

Deficit

 

Equity

Common stock subject to possible redemption – As Previously Reported

    

(21,780,266)

    

$

(2,178)

    

$

(217,769,259)

    

$

 —

    

$

(217,771,437)

Common stock subject to possible redemption – Adjustments

 

1,978,284

 

 

198

 

 

19,779,809

 

 

 —

 

 

19,780,007

Common stock subject to possible redemption – As Restated

 

(19,801,982)

 

 

(1,980)

 

 

(197,989,450)

 

 

 —

 

 

(197,991,430)

Net loss – As Previously Reported

 

 —

 

 

 —

 

 

 —

 

 

(202,287)

 

 

(202,287)

Net loss – Adjustments

 

 —

 

 

 —

 

 

 —

 

 

(2,291,379)

 

 

(2,291,379)

Net loss – As Restated

 

 —

 

 

 —

 

 

 —

 

 

(2,493,666)

 

 

(2,493,666)

Balance at December 31, 2020 – As

 

  

 

 

  

 

 

  

 

 

  

 

 

  

Previously Reported

 

6,969,734

 

 

697

 

 

5,201,592

 

 

(202,287)

 

 

5,000,002

Balance at December 31, 2020 – Adjustments

 

1,978,284

 

 

198

 

 

2,291,188

 

 

(2,291,379)

 

 

 7

Balance at December 31, 2020 – As Restated

 

8,948,018

 

 

895

 

 

7,492,780

 

 

(2,493,666)

 

 

5,000,009